502 related articles for article (PubMed ID: 1682337)
21. Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.
Jansen RW; Schols D; Pauwels R; De Clercq E; Meijer DK
Mol Pharmacol; 1993 Nov; 44(5):1003-7. PubMed ID: 7902528
[TBL] [Abstract][Full Text] [Related]
22. Effects of serotonin and melanin on in vitro HIV-1 infection.
Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
[TBL] [Abstract][Full Text] [Related]
23. HIV-1 gp 120 blocks jacalin-induced proliferative response in CD4+ T cells: jacalin as a useful surrogate marker for qualitative and quantitative deficiency of CD4+ T cells in HIV-1 infection.
Tamma SM; Oyaizu N; McCloskey TW; Kalyanaraman VS; Pahwa S
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 1):290-7. PubMed ID: 8811050
[TBL] [Abstract][Full Text] [Related]
24. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
[TBL] [Abstract][Full Text] [Related]
25. Population dynamics of HIV within an individual after treatment with zidovudine.
McLean AR; Emery VC; Webster A; Griffiths PD
AIDS; 1991 May; 5(5):485-9. PubMed ID: 1677807
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the disinfectant effect of Solprogel against human immunodeficiency virus type 1 (HIV-1).
Hernández A; Belda FJ; Domínguez J; Matas L; Gimenez M; Caraballo M; Ramil C; Ausina V
J Hosp Infect; 1996 Nov; 34(3):223-8. PubMed ID: 8923278
[TBL] [Abstract][Full Text] [Related]
27. HIV virions and HIV infection in vitro are unaffected by human granzymes A and B.
Mackewicz CE; Lieberman J; Froelich C; Levy JA
AIDS Res Hum Retroviruses; 2000 Mar; 16(4):367-72. PubMed ID: 10716374
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human immunodeficiency virus infection of CD4+ cells by CD4-free glycopeptides from monocytic U937 cells.
Mbemba E; Carré V; Atemezem A; Saffar L; Gluckman JC; Gattegno L
AIDS Res Hum Retroviruses; 1996 Jan; 12(1):47-53. PubMed ID: 8825618
[TBL] [Abstract][Full Text] [Related]
29. Rapid screening of antiretroviral combinations.
St Clair M; Pennington KN; Rooney J; Barry DW
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S24-7. PubMed ID: 8595504
[TBL] [Abstract][Full Text] [Related]
30. Human immunodeficiency virus (HIV) type 1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range.
Le Guern M; Levy JA
Proc Natl Acad Sci U S A; 1992 Jan; 89(1):363-7. PubMed ID: 1346069
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of human immunodeficiency virus type 1 (HIV-1) penetration into target cells by synthetic peptides mimicking the N-terminus of the HIV-1 transmembrane glycoprotein.
Slepushkin VA; Kornilaeva GV; Andreev SM; Sidorova MV; Petrukhina AO; Matsevich GR; Raduk SV; Grigoriev VB; Makarova TV; Lukashov VV
Virology; 1993 May; 194(1):294-301. PubMed ID: 7683157
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of HIV-1 entry into CD4+ T cells.
Stein BS; Engleman EG
Adv Exp Med Biol; 1991; 300():71-86; discussion 87-96. PubMed ID: 1685857
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of human immunodeficiency virus type 1 phenotypes in infected children.
Spencer LT; Ogino MT; Dankner WM; Spector SA
J Infect Dis; 1994 Mar; 169(3):491-5. PubMed ID: 7908924
[TBL] [Abstract][Full Text] [Related]
34. P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load.
Minuesa G; Arimany-Nardi C; Erkizia I; Cedeño S; Moltó J; Clotet B; Pastor-Anglada M; Martinez-Picado J
J Antimicrob Chemother; 2016 Oct; 71(10):2782-92. PubMed ID: 27334660
[TBL] [Abstract][Full Text] [Related]
35. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of HIV-1 infectivity with curdlan sulfate in vitro.
Kaneko Y; Yoshida O; Nakagawa R; Yoshida T; Date M; Ogihara S; Shioya S; Matsuzawa Y; Nagashima N; Irie Y
Biochem Pharmacol; 1990 Feb; 39(4):793-7. PubMed ID: 1968342
[No Abstract] [Full Text] [Related]
37. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.
Easmon J; Heinisch G; Holzer W; Rosenwirth B
J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751
[TBL] [Abstract][Full Text] [Related]
38. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of HIV infection by baicalin--a flavonoid compound purified from Chinese herbal medicine.
Li BQ; Fu T; Yan YD; Baylor NW; Ruscetti FW; Kung HF
Cell Mol Biol Res; 1993; 39(2):119-24. PubMed ID: 7693133
[TBL] [Abstract][Full Text] [Related]
40. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1.
Schols D; Pauwels R; Desmyter J; De Clercq E
Virology; 1990 Apr; 175(2):556-61. PubMed ID: 1691563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
